IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP II, LLC

Q2 2018 Holdings

Filed 2018-08-07 | 4 holdings | $176.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$78.4K10,230,34944.4%
Blueprint Medicines Corporation(2L9)COM09627Y109$55.8K878,87531.6%
Allena Pharmaceuticals, Inc.(ALNAEUR)COM018119107$36.4K2,790,96420.6%
Sage Therapeutics, Inc.(SG7)COM78667J108$5.8K37,3623.3%